cipla

India-based Cipla gets new chief financial officer

pharmafile | June 8, 2016 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys 

Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief financial officer.

The India-based pharma company had already appointed another senior Dr. Reddy’s executive, Umang Vohra, as its chief operating officer and this new move will see Upadhye leave his role as VP, global generics finance and head of investor relations to become CFO at Cipla.

The board at the company has approved the appointment and Upadhye will begin his role no later than August 16 2016.

Advertisement

India’s fifth largest drugmaker by sales posted disappointing results for Q4 of last year, with a 69% fall in profits from the same period the previous year. Among its many drugs are the anti-depressant, Escitalopram, HIV antiretroviral medicine, Limivudine, and corticosteroid, fluticasone propionate.

Related Content

bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the …

andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s …

facilities_lg06

Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc …

The Gateway to Local Adoption Series

Latest content